Research Article| Volume 163, ISSUE 1, P94-98, February 01, 1999

Download started.


Consensus statement on the diagnosis of multiple system atrophy


      We report the results of a consensus conference on the diagnosis of multiple system atrophy (MSA). We describe the clinical features of the disease, which include four domains: autonomic failure/urinary dysfunction, parkinsonism and cerebellar ataxia, and corticospinal dysfunction. We set criteria to define the relative importance of these features. The diagnosis of possible MSA requires one criterion plus two features from separate other domains. The diagnosis of probable MSA requires the criterion for autonomic failure/urinary dysfunction plus poorly levodopa responsive parkinsonism or cerebellar ataxia. The diagnosis of definite MSA requires pathological confirmation.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Albanese A
        • Colosimo C
        • Bentivoglio AR
        • Fenici R
        • Melillo G
        • Colosimo C
        • Tonali P
        Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria.
        J Neurol Neurosurg Psychiatry. 1995; 59: 144-151
        • Beck RO
        • Betts CD
        • Fowler CJ
        Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases.
        J Urol. 1994; 151: 1336-1341
      1. Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 1996;46:1470.

      2. Daniel SE. The neuropathology and neurochemistry of multiple system atrophy. In: Bannister R, Mathias CJ, editors. Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. Oxford: Oxford University Press, 1992:564–585.

      3. Fahn S, Elton R. Unified Parkinson's disease rating scale committee: unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne I, editors. Recent developments in Parkinson's disease. New York: Macmillan, 1987:153–164.

      4. Gilman S. Multiple system atrophy. In: Jankovic J, Tolosa E, editors. Parkinson's disease and movement disorders, 3rd edn. Baltimore: Williams and Wilkins, 1998:245–262.

        • Graham JG
        • Oppenheimer DR
        Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy.
        J Neurol Neurosurg Psychiatry. 1969; 32: 28-34
        • Hughes AJ
        • Colosimo C
        • Kleedorfer B
        • Daniel SE
        • Lees AJ
        The dopaminergic response in multiple system atrophy.
        J Neurol Neurosurg Psychiatry. 1992; 55: 1009-1013
        • Klockgether T
        • Lüdtke R
        • Kramer B
        • Abele M
        • Bürk K
        • Schöls L
        • Riess O
        • Laccone F
        • Boesch S
        • Lopes-Cendes I
        • Brice A
        • Inzelberg R
        • Zilber N
        • Dichgans J
        The natural history of degenerative ataxia: a retrospective study in 466 patients.
        Brain. 1998; 121: 589-600
        • Kluin KJ
        • Gilman S
        • Lohman M
        • Junck L
        Characteristics of the dysarthria of multiple system atrophy.
        Arch Neurol. 1996; 53: 545-548
        • Lang AE
        • Curran T
        • Provias J
        • Bergeron C
        Striatonigral degeneration: iron deposition in putamen correlates with the slit-like void signal of magnetic resonance imaging.
        Can J Neurol Sci. 1994; 21: 311-318
        • Lantos PL
        Multiple system atrophy.
        Brain Pathol. 1997; 7: 1293-1297
        • Litvan I
        • Agid Y
        • Calne D
        • Campbell G
        • Dubois B
        • Duvoisin RC
        • Goetz C
        • Golbe LI
        • Grafman J
        • Growdon JH
        • Hallett M
        • Jankovic J
        • Quinn N
        • Tolosa E
        • Zee DS
        NINDS-SPSP clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
        Neurology. 1996; 47: 1-9
        • Litvan I
        • Goetz CG
        • Jankovic J
        • Wenning GK
        • Booth V
        • Bartko JJ
        • McKee A
        • Jellinger K
        • Lai EC
        • Brandel J-P
        • Verny M
        • Chaudhuri KR
        • Pearce RKB
        • Agid Y
        What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study.
        Arch Neurol. 1997; 54: 937-944
        • Low PA
        The composite autonomic scoring scale for the laboratory quantitation of generalized autonomic failure.
        Mayo Clin Proc. 1993; 68: 748-752
        • Mathias CJ
        Autonomic dysfunction.
        Br J Hosp Med. 1987; 38: 238-243
      5. Mathias CJ, Bannister R. Investigation of autonomic disorders. In: Bannister R, Mathias CJ, editors. Autonomic failure. A textbook of clinical disorders of the autonomic nervous system, 3rd edn. Oxford: Oxford University Press, 1992:255–290.

      6. Mathias CJ, Williams AC. The Shy Drager syndrome (and multiple system atrophy). In: Calne DB, editor. Neurodegenerative diseases. Philadelphia: WB Saunders, 1994:743–768.

        • Palace J
        • Chandiramani VA
        • Fowler CJ
        Value of sphincter electromyography in the diagnosis of multiple system atrophy.
        Muscle Nerve. 1997; 20: 1396-1403
        • Parati EA
        • Fetoni V
        • Geminiani GC
        • Soliveri P
        • Giovannini P
        • Testa D
        • Genitrini S
        • Caraceni T
        • Girotti F
        Response to l-DOPA in multiple system atrophy.
        Clin Neuropharmacol. 1993; 16: 139-144
      7. Quinn N. Multiple system atrophy. In: Marsden CD, Fahn S, editors. Movement disorders 3. London: Butterworths, 1996:262–281.

        • Sandroni P
        • Ahlskog JE
        • Fealey RD
        • Low PA
        Autonomic involvement in extrapyramidal and cerebellar disorders.
        Clin Auton Res. 1991; 1: 147-155
      8. Schrag A, Kingsley D, Phatouros C, Mathias CJ, Lees AJ, Daniel SE, Quinn NP. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry 1998:in press.

        • Schulz JB
        • Klockgether T
        • Petersen D
        • Jauch M
        • Muller-Schauenburg W
        • Spieker S
        • Voigt K
        • Dichgans J
        Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT.
        J Neurol Neurosurg Psychiatry. 1994; 57: 1047-1056
        • Testa D
        • Savoiardo M
        • Fetoni V
        • Strada L
        • Palazzini E
        • Bertulezzi G
        • Girotti F
        Multiple system atrophy. Clinical and MR observations on 42 cases.
        Ital J Neuro Sci. 1993; 14: 211-216
        • Wenning GK
        • Ben-Shlomo Y
        • Magalaes M
        • Daniel SE
        • Quinn NP
        Clinical features and natural history of multiple system atrophy: an analysis of 100 cases.
        Brain. 1994; 117: 835-845